Cargando…
Lung Cancer Proteomics: Recent Advances in Biomarker Discovery
Lung cancer is the most common cause of cancer death in both men and women in Western countries, with a 5-year survival rate of 15%, which is among the lowest of all cancers. The high mortality from lung cancer is due not only to the late stage diagnosis but also to the lack of effective treatments...
Autores principales: | Indovina, Paola, Marcelli, Eleonora, Maranta, Pasquale, Tarro, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196861/ https://www.ncbi.nlm.nih.gov/pubmed/22229091 http://dx.doi.org/10.1155/2011/726869 |
Ejemplares similares
-
Recent Advances in Proteomics and Cancer Biomarker Discovery
por: Xiao, Gary Guishan, et al.
Publicado: (2008) -
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
por: Kwon, Yang Woo, et al.
Publicado: (2021) -
Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
por: Sallam, Reem M.
Publicado: (2015) -
Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
por: Luu, Anita K., et al.
Publicado: (2021) -
Revisiting biomarker discovery by plasma proteomics
por: Geyer, Philipp E, et al.
Publicado: (2017)